UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000015477
Receipt number R000017478
Scientific Title A study of the effect of the self-care support program created by nurses in order to enhance diet satisfaction for chemotherapy patients with breast cancer who suffer from taste alteration
Date of disclosure of the study information 2014/10/21
Last modified on 2019/06/02 14:06:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study of the effect of the self-care support program created by nurses in order to enhance diet satisfaction for chemotherapy patients with breast cancer who suffer from taste alteration

Acronym

A study of the effect of the self-care support program created by nurses in order to enhance diet satisfaction for chemotherapy patients with breast cancer who suffer from taste alteration

Scientific Title

A study of the effect of the self-care support program created by nurses in order to enhance diet satisfaction for chemotherapy patients with breast cancer who suffer from taste alteration

Scientific Title:Acronym

A study of the effect of the self-care support program created by nurses in order to enhance diet satisfaction for chemotherapy patients with breast cancer who suffer from taste alteration

Region

Japan


Condition

Condition

Breast Cancer

Classification by specialty

Breast surgery Nursing

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Examination of the effect of the intervention for diet satisfaction for taste alteration associated with the chemotherapy

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The satisfaction level of the diet by the taste alteration

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

The support by the nurse using the brochure about the taste alteration

Interventions/Control_2

Usually support care by the nurse

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

1.The women who were diagnosed as breast cancer newly.
2.20 years of age or over.
3.The patients who receive chemotherapy ( anthracyclines and taxanes)before or after operation.
4.Eastern Cooperative Oncology Group (ECOG) performance status 0 to 1.
5.The patients who do not have taste alteration and oral complication or dysphagia.
6.The patients who agree with the study and do not have communication disorder.

Key exclusion criteria

1.The patients stage 4 with advanced breast cancer or the patients recurrent with breast cancer.
2.The patients who received chemotherapy previously because of cancer treatment.
3.The patients who received radiotherapy to oral cavity or salivary gland previously.
4.The patients who had operation to oral cavity previously.
5.The patients who take a medicine which contains zinc currently or previously because of taste alteration.
6.The patients with serious renal disease(more than serum Cr 2.0mg/dL), or receive dialysis.
7.The patients with serious liver disease.
8.The patients with hepatic disorder, mental disorder, an oral cavity malignant tumor and the diabetes.
9.The patients who have already taken a supplement which contains zinc or a medicine which contains zinc.
10.Patients who are excluded by the doctor&#39;s judgment.

Target sample size

150


Research contact person

Name of lead principal investigator

1st name Kazuaki
Middle name
Last name Tanabe

Organization

Hiroshima University Graduate School of Biomedical & Health Sciences

Division name

Department of Health Care for Adults

Zip code

734-8553

Address

1-2-3 Kasumi, Minamiku-ku, Hiroshima City, Hiroshima prefecture

TEL

082-257-5383

Email

ktanae2@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name Sanae
Middle name
Last name Asano

Organization

Hiroshima University Graduate School of Biomedical & Health Sciences

Division name

Department of Health Care for Adults

Zip code

734-8553

Address

1-2-3 Kasumi, Minamiku-ku, Hiroshima City, Hiroshima prefecture

TEL

082-257-5383

Homepage URL


Email

asano-sanae@hiroshima-u.ac.jp


Sponsor or person

Institute

Hiroshima University Graduate School of Biomedical & Health Sciences

Institute

Department

Personal name



Funding Source

Organization

YAMAJI FUMIKO NURSING RESERACH FUND

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hiroshima Univercity Hospital

Address

1-2-3 Kasumi, Minamiku-ku, Hiroshima City, Hiroshima prefecture

Tel

082-257-5907

Email

kasumi-kenkyu@office.hiroshima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 10 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

88

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 09 Month 17 Day

Date of IRB


Anticipated trial start date

2014 Year 10 Month 24 Day

Last follow-up date

2018 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 10 Month 20 Day

Last modified on

2019 Year 06 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017478


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name